Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesis.
Benedikt SchäfgenMarija JuskicMarcus RadickeMadeleine HertelRichard BarrAndré PfobRiku TogawaJuliane NeesAlexandra von AuSarah FastnerAba HarcosChristina GomezAnne StieberFabian RiedelAndré HennigsChristof SohnJoerg HeilMichael GolattaPublished in: European radiology (2020)
• The FUSION-X-US-II prototype allows the combination of automated breast ultrasound and digital breast tomosynthesis in a single device without decompression of the breast. • Image quality and coverage of ABUS are sufficient to accurately detect malignant breast lesions. • If tomosynthesis and ABUS should become part of breast cancer screening, the combination of both techniques in one device could offer practical and logistic advantages. To evaluate a potential benefit of a combination of ABUS and tomosynthesis in screening-like settings, further studies are needed.